US Patent 12071450 Salts of conjugates for cancer therapy
Patent 12071450 was granted and assigned to Biosight Ltd. on August, 2024 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
August 30, 2021
0
Date of Patent
August 27, 2024
0
Patent Applicant
Patent Application Number
17460335
0
Patent Inventor Names
Stela Gengrinovitch
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 12071450 Salts of conjugates for cancer therapy
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
